Cis binding between inhibitory receptors and MHC class I can regulate mast cell activation

Journal of Experimental Medicine

Volumn 204, Issue 4, 2007, Pages 907-920

  Masuda, Ai ^a   Nakamura, Akira ^a   Maeda, Tsutomu ^a   Sakamoto, Yuzuru ^a   Takai, Toshiyuki ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; IMMUNOGLOBULIN RECEPTOR; LEUKOCYTE IMMUNOGLOBULIN LIKE RECEPTOR B; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PAIRED IMMUNOGLOBULIN LIKE RECEPTOR B; UNCLASSIFIED DRUG;

ANAPHYLAXIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLUORESCENCE; HUMAN; HUMAN CELL; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; BETA 2-MICROGLOBULIN; CELL LINE; CHEMOKINES; CYTOKINES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; LIPOPOLYSACCHARIDES; MAST CELLS; MEMBRANE GLYCOPROTEINS; MICE; MICE, KNOCKOUT; PROTEIN BINDING; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION;

EID: 34247323402     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20060631     Document Type: Article

References (53)

1. Kawakami, T., and S.J. Galli. 2002. Regulation of mast-cell and basophil function and survival by IgE. Nat. Rev. Immunol. 2:773-786.
2. Marshall, J.S. 2004. Mast-cell responses to pathogens. Nat. Rev. Immunol. 4:787-799.
3. Gibbs, B.F. 2005. Human basophils as effectors and immunomodulators of allergic inflammation and innate immunity. Clin. Exp. Med. 5:43-49.
4. Galli, S.J., S. Nakae, and M. Tsai. 2005. Mast cells in the development of adaptive immune responses. Nat. Immunol. 6:135-143.
5. Kinet, J.P. 1999. The high-affi nity IgE receptor (FcεRI): from physiology to pathology. Annu. Rev. Immunol. 17:931-972.
6. Asai, K., J. Kitaura, Y. Kawakami, N. Yamagata, M. Tsai, D.P. Carbone, F.T. Liu, S.J. Galli, and T. Kawakami. 2001. Regulation of mast cell survival by IgE. Immunity. 14:791-800.
7. Katz, H.R. 2002. Inhibitory receptors and allergy. Curr. Opin. Immunol. 14:698-704.
8. Takai, T., M. Ono, M. Hikida, H. Ohmori, and J.V. Ravetch. 1996. Augmented humoral and anaphylactic responses in FcγRIIB-deficient mice. Nature. 379:346-349.
9. Licht, A., I. Pecht, and R. Schweitzer-Stenner. 2005. Regulation of mast cells' secretory response by co-clustering the type 1 Fcε receptor with the mast cell function-associated antigen. Eur. J. Immunol. 35:1621-1633.
10. Daheshia, M., D.S. Friend, M.J. Grusby, K.F. Austen, and H.R. Katz. 2001. Increased severity of local and systemic anaphylactic reactions in gp49B1-deficient mice. J. Exp. Med. 194:227-234.
11. Colonna, M., H. Nakajima, F. Navarro, and M. Lopez-Botet. 1999. A novel family of Ig-like receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells. J. Leukoc. Biol. 66:375-381.
12. Colonna, M., H. Nakajima, and M. Cella. 2000. A family of inhibitory and activating Ig-like receptors that modulate function of lymphoid and myeloid cells. Semin. Immunol. 12:121-127.
13. Sloane, D.E., N. Tedla, M. Awoniyi, D.W. Macglashan Jr., L. Borges, K.F. Austen, and J.P. Arm. 2004. Leukocyte immunoglobulin-like receptors: novel innate receptors for human basophil activation and inhibition. Blood. 104:2832-2839.
14. Brown, D., J. Trowsdale, and R. Allen. 2004. The LILR family: modulators of innate and adaptive immune pathways in health and disease. Tissue Antigens. 64:215-225.
15. Hayami, K., D. Fukuta, Y. Nishikawa, Y. Yamashita, M. Inui, Y. Ohyama, M. Hikida, H. Ohmori, and T. Takai. 1997. Molecular cloning of a novel murine cell-surface glycoprotein homologous to killer cell inhibitory receptors. J. Biol. Chem. 272:7320-7327.
16. Kubagawa, H., P.D. Burrows, and M.D. Cooper. 1997. A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells. Proc. Natl. Acad. Sci. USA. 94:5261-5266.
17. Yamashita, Y., D. Fukuta, A. Tsuji, A. Nagabukuro, Y. Matsuda, Y. Nishikawa, Y. Ohyama, H. Ohmori, M. Ono, and T. Takai. 1998. Genomic structures and chromosomal location of p91, a novel murine regulatory receptor family. J. Biochem. (Tokyo). 123:358-368.
18. Kubagawa, H., C.C. Chen, L.H. Ho, T.S. Shimada, L. Gartland, C. Mashburn, T. Uehara, J.V. Ravetch, and M.D. Cooper. 1999. Biochemical nature and cellular distribution of the paired immunoglobulin-like receptors, PIR-A and PIR-B. J. Exp. Med. 189:309-318.
19. Maeda, A., M. Kurosaki, and T. Kurosaki. 1998. Paired immunoglobulin-like receptor (PIR)-A is involved in activating mast cells through its association with Fc receptor γ chain. J. Exp. Med. 188:991-995.
20. Yamashita, Y., M. Ono, and T. Takai. 1998. Inhibitory and stimulatory functions of paired Ig-like receptor (PIR) family in RBL-2H3 cells. J. Immunol. 161:4042-4047.
21. Ono, M., T. Yuasa, C. Ra, and T. Takai. 1999. Stimulatory function of paired immunoglobulin-like receptor-A in mast cell line by associating with subunits common to Fc receptors. J. Biol. Chem. 274:30288-30296.
22. Bléry, M., H. Kubagawa, C.C. Chen, F. Vely, M.D. Cooper, and E. Vivier. 1998. The paired Ig-like receptor PIR-B is an inhibitory receptor that recruits the protein-tyrosine phosphatase SHP-1. Proc. Natl. Acad. Sci. USA. 95:2446-2451.
23. Maeda, A., M. Kurosaki, M. Ono, T. Takai, and T. Kurosaki. 1998. Requirement of SH2-containing protein tyrosine phosphatases SHP-1 and SHP-2 for paired immunoglobulin-like receptor B (PIR-B)-mediated inhibitory signal. J. Exp. Med. 187:1355-1360.
24. Uehara, T., M. Bléry, D.W. Kang, C.C. Chen, L.H. Ho, G.L. Gartland, F.T. Liu, E. Vivier, M.D. Cooper, and H. Kubagawa. 2001. Inhibition of IgE-mediated mast cell activation by the paired Ig-like receptor PIR-B. J. Clin. Invest. 108:1041-1050.
25. -/- mice. Nat. Immunol. 5:623-629.
26. Kärre, K. 1993. Natural killer cells and the MHC class I pathway of peptide presentation. Semin. Immunol. 5:127-145.
27. Parham, P., and K.L. McQueen. 2003. Alloreactive killer cells: hindrance and help for haematopoietic transplants. Nat. Rev. Immunol. 3:108-122.
28. Vivier, E., and N. Anfossi. 2004. Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future. Nat. Rev. Immunol. 4:190-198.
29. Parham, P. 2005. MHC class I molecules and KIRs in human history, health and survival. Nat. Rev. Immunol. 5:201-214.
30. Moretta, L., and A. Moretta. 2004. Killer immunoglobulin-like receptors. Curr. Opin. Immunol. 16:626-633.
31. Borrego, F., M. Masilamani, J. Kabat, T.B. Sanni, and J.E. Coligan. 2005. The cell biology of the human natural killer cell CD94/NKG2A inhibitory receptor. Mol. Immunol. 42:485-488.
32. Hamerman, J.A., K. Ogasawara, and L.L. Lanier. 2005. NK cells in innate immunity. Curr. Opin. Immunol. 17:29-35.
33. Doucey, M.A., L. Scarpellino, J. Zimmer, P. Guillaume, L.F. Luescher, C. Bron, and W. Held. 2004. Cis association of Ly49A with MHC class I restricts natural killer cell inhibition. Nat. Immunol. 5:328-336.
34. -/- mice. Nat. Immunol. 3:542-548.
35. Horváth, G., M. Petrás, G. Szentesi, A. Fábián, J.W. Park, G. Vereb, and J. Szöllösi. 2005. Selecting the right fluorophores and flow cytometer for fluorescence resonance energy transfer measurements. Cytometry A. 65:148-157.
36. Takai, T., M. Li, D. Sylvestre, R. Clynes, and J.V. Ravetch. 1994. FcRγ chain deletion results in pleiotrophic effector cell defects. Cell. 76:519-529.
37. b. Proc. Natl. Acad. Sci. USA. 83:7447-7451.
38. 2 microglobulin-negative cells. J. Exp. Med. 176:829-834.
39. Kharitonenkov, A., Z. Chen, I. Sures, H. Wang, J. Schilling, and A. Ullrich. 1997. A family of proteins that inhibit signalling through tyrosine kinase receptors. Nature. 386:181-186.
40. Ujike, A., Y. Ishikawa, M. Ono, T. Yuasa, T. Yoshino, M. Fukumoto, J.V. Ravetch, and T. Takai. 1999. Modulation of immunoglobulin (Ig) E-mediated systemic anaphylaxis by low-affi nity Fc receptors for IgG. J. Exp. Med. 189:1573-1579.
41. Cookson, W. 1999. The alliance of genes and environment in asthma and allergy. Nature. 402:B5-B11.
42. Colonna, M., F. Navarro, T. Bellon, M. Llano, P. Garcia, J. Samaridis, L. Angman, M. Cella, and M.A. Lopez-Botet. 1997. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J. Exp. Med. 186:1809-1818.
43. Colonna, M., J. Samaridis, M. Cella, L. Angman, R.L. Allen, C.A. O'Callaghan, R. Dunbar, G.S. Ogg, V. Cerundolo, and A. Rolink. 1998. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J. Immunol. 160:3096-3100.
44. Leibson, P.J., and L.R. Pease. 2004. Having it both ways: MHC recognition in cis and trans. Nat. Immunol. 5:237-238.
45. Willcox, B.E., L.M. Thomas, and P.J. Bjorkman. 2003. Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor. Nat. Immunol. 4:913-919.
46. S cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat. Immunol. 3:237-243.
47. Ho, L.H., T. Uehara, C.C. Chen, H. Kubagawa, and M.D. Cooper. 1999. Constitutive tyrosine phosphorylation of the inhibitory paired Ig-like receptor PIR-B. Proc. Natl. Acad. Sci. USA. 96:15086-15090.
48. Kollnberger, S., L.A. Bird, M. Roddis, C. Hacquard-Bouder, H. Kubagawa, H.C. Bodmer, M. Breban, A.I. McMichael, and P. Bowness. 2004. HLA-B27 heavy chain homodimers are expressed in HLA-B27 transgenic rodent models of spondyloarthritis and are ligands for paired Ig-like receptors. J. Immunol. 173:1699-1710.
49. Pereira, S., H. Zhang, T. Takai, and C.A. Lowell. 2004. The inhibitory receptor PIR-B negatively regulates neutrophil and macrophage integrin signaling. J. Immunol. 173:5757-5765.
50. Zhang, H., F. Meng, C.L. Chu, T. Takai, and C.A. Lowell. 2005. The Src family kinases Hck and Fgr negatively regulate neutrophil and dendritic cell chemokine signaling via PIR-B. Immunity. 22:235-246.
51. Hara, T., K. Yamada, and H. Tachibana. 1998. Basophilic differentiation of the human leukemia cell line KU812 upon treatment with interleukin-4. Biochem. Biophys. Res. Commun. 247:542-548.
52. Hosoda, M., M. Yamaya, T. Suzuki, N. Yamada, M. Kamanaka, K. Sekizawa, J.H. Butterfield, T. Watanabe, H. Nishimura, and H. Sasaki. 2002. Effects of rhinovirus infection on histamine and cytokine production by cell lines from human mast cells and basophils. J. Immunol. 169:1482-1491.
53. Feige, J.N., D. Sage, W. Wahli, B. Desvergne, and L. Gelman. 2005. PixFRET, an ImageJ plug-in for FRET calculation that can accommodate variations in spectral bleed-throughs. Microsc. Res. Tech. 68:51-58.